1[1]Srivastava P K,Menoret A,Basu S,et al.Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world[J].Immunity,1998,8(6): 657-665.
2[2]Melcher A,Todryk A,Hardwick N,et al.Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression[J].Nat Med,1998,4(5): 581-587.
3[3]Blachere NE,Udono H,Janetzki S,et al.Heat shock protein vaccines against cancer[J].J Immunother,1993; 14(4): 352-356
4[4]Udono H,Srivastava PK.Comparison of tumor-specific immunogenicities of stress-induced proteins gp96,HSP90,and HSP70[ J].J Immunol,1994; 152(11): 5398-5403.
5[5]Udono H,Srivastava PK.Heat shock protein 70-associated pepfides elicit specific cancer immunity[J].J Exp Med,1993,178(4): 1391-1396.
6[6]Peng P,Menoret A,Srivastava PK.Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography[J].J Immunol Methods,1997,204(1): 13-21.
7[7]Zhu X,Zhao X,Burkholder WF,et al.Structural analysis of substrate binding by the molecular chaperone DnaK [ J ].Science,1996,272(5268): 1606-1614.
8[8]Boice JA,Hightower LE.A mutational study of the peptide-binding domain of Hsc70 guided by secondary structure prediction[ J].J Biol Chem,1997,272(40): 24825-24831.
9[9]Scheibel T,Weikl T,Buchner J.Two chaperone sites in HSP90differing in substrate specificity and ATP dependence [ J ].Proc Natl Acad Sci USA,1998,95(4): 1495-1499.
10[10]Linderoth NA,Popowicz A,Sastry S.Identification of the peptidebinding site in the heat shock chaperone/tumor rejection antigen gp96 (Grp94)[J].J Biol Chem,2000,275(8): 5472-5477.
同被引文献38
1Stuart RA, Cyr DM, Neupert W, et al. Hsp70 in mitochondrial biogenesis: from chaperoning nascent polypeptide chain to facilitation of protein degradation[J].Experientia, 1994, 50:1002.
2Hard FU. Molecular chaperones in cellular protein folding[J] .Nature, 1996, 381 : 571
3Heikema A, Agsteribbe E, Wilshut J, et al. Generation of heat shock protein-based vaccines by intracellular loading of gp96 with antigenic peptides[J]. Immunol Lett, 1997, 57(1) :69-74.
4Blachere NE, Li Z, Chandawarkar RY, et al. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity[J]. J Exp Med, 1997, 186(8) : 1315-- 1322.
5Melcher A, Todryk A, Hardwick N, et al. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression[ J ]. Nat Med, 1998, 4 (5) : 581-587
6Srivastava PK, Old LJ. Individually distinct transplantation antigens of chemically induced mouse tumor[J]. Immunol Today,1988, 9 : 78--83.
7Blachere NE, Udono H, Janetzki S, et al. Heat shock protein vaccines against cancer[ J ]. J Immunother, 1993, 14 ( 4 ) : 352-356.
8Udono H, Srivastava PK. Comparison of tumor-specific immunogenicities of stress-induced protein gp96, HSP90 and HSP70[J].J Immunol, 1994, 152(11):5398-5403.
9Srivastava PK. Peptide-binding heat shock protein in the endoplasmic reticulum : role in immune response to cancer and in antigen presentation[J]. Adv Cancer Res, 1993, 62:153--177.
10Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides[J]. Science,1995, 269:1585.
